Immunogenetic protective factors in Genetic Generalized Epilepsy.


Journal

Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089

Informations de publication

Date de publication:
10 2020
Historique:
received: 15 04 2020
revised: 02 06 2020
accepted: 10 06 2020
pubmed: 26 6 2020
medline: 7 10 2021
entrez: 26 6 2020
Statut: ppublish

Résumé

Genetic Generalized Epilepsies (GGEs) are a heterogeneous group of syndromes characterized by generalized seizure activity that affects both hemispheres, with mainly genetic causes. Neuroinflammation has been established as an important mechanism in epileptogenesis. The ability to develop an appropriated immune response is strongly determined by immunogenetic factors. In this setting, our aim was to evaluate potential associations between GGEs and immunogenetic factors. The rs16944 (IL-1β -511 T > C) polymorphism and the HLA-DRB1 locus were genotyped in a Portuguese GGE population. Association with two clinicopathological features, photosensitivity and refractoriness, was investigated. This case-control study included 323 GGE patients (187 F, 136 M, 34.0 ± 13.9 years of age), 145 of which with JME diagnosis (88 F, 57 M, 34.1 ± 14.0 years), and 282 healthy controls (174 F, 108 M, 37.7 ± 11.6 years). Decreased frequencies of the HLA-DRB1*09 and DRB1*13 alleles were observed in the GGE population. HLA-DRB1*07 frequency was increased in JME. Rs16944 allelic frequencies were similar between patients and controls. These results, not entirely consistent with previous reports, suggest that HLA molecules may have a complex role in epileptogenesis.

Sections du résumé

BACKGROUND
Genetic Generalized Epilepsies (GGEs) are a heterogeneous group of syndromes characterized by generalized seizure activity that affects both hemispheres, with mainly genetic causes. Neuroinflammation has been established as an important mechanism in epileptogenesis. The ability to develop an appropriated immune response is strongly determined by immunogenetic factors. In this setting, our aim was to evaluate potential associations between GGEs and immunogenetic factors.
METHODS
The rs16944 (IL-1β -511 T > C) polymorphism and the HLA-DRB1 locus were genotyped in a Portuguese GGE population. Association with two clinicopathological features, photosensitivity and refractoriness, was investigated. This case-control study included 323 GGE patients (187 F, 136 M, 34.0 ± 13.9 years of age), 145 of which with JME diagnosis (88 F, 57 M, 34.1 ± 14.0 years), and 282 healthy controls (174 F, 108 M, 37.7 ± 11.6 years).
RESULTS
Decreased frequencies of the HLA-DRB1*09 and DRB1*13 alleles were observed in the GGE population. HLA-DRB1*07 frequency was increased in JME. Rs16944 allelic frequencies were similar between patients and controls.
CONCLUSIONS
These results, not entirely consistent with previous reports, suggest that HLA molecules may have a complex role in epileptogenesis.

Identifiants

pubmed: 32585211
pii: S0920-1211(20)30236-9
doi: 10.1016/j.eplepsyres.2020.106396
pii:
doi:

Substances chimiques

HLA-DRB1 Chains 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106396

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

João Chaves (J)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Serviço de Neurologia, Hospital de Santo António, Centro Hospitalar Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal.

Ricardo Martins-Ferreira (R)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Ana Marta Ferreira (AM)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Sandra Brás (S)

Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Cláudia Carvalho (C)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Andreia Bettencourt (A)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Raquel Samões (R)

Serviço de Neurologia, Hospital de Santo António, Centro Hospitalar Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal.

Fábio Monteiro (F)

Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Joel Freitas (J)

Serviço de Neurofisiologia, Hospital de Santo António - Centro Hospitalar Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal.

Rui Chorão (R)

Serviço de Neurologia, Hospital de Santo António, Centro Hospitalar Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal.

João Lopes (J)

Serviço de Neurofisiologia, Hospital de Santo António - Centro Hospitalar Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal.

João Ramalheira (J)

Serviço de Neurofisiologia, Hospital de Santo António - Centro Hospitalar Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal.

Berta Martins da Silva (BM)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Paulo Pinho Costa (PP)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Porto. Rua Pedro Nunes, n. º 88, 4099-032 Porto, Portugal.

António Martins da Silva (AM)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Serviço de Neurofisiologia, Hospital de Santo António - Centro Hospitalar Universitário do Porto, Largo Prof. Abel Salazar, 4099-003 Porto, Portugal.

Bárbara Leal (B)

UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Lab. Imunogenética, DPIM, ICBAS-UPorto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: baguerraleal@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH